Qsemble Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Qsemble Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.66M	Buy	76,793 +48,266	+169%	+$2.81M	0.36%	98
2025 Q4	$1.54M	Sell	28,527 -207,418	-88%	-$9.98M	0.13%	222
2025 Q3	$10.6M	Buy	235,945 +115,006	+95%	+$5.37M	1.04%	3
2025 Q2	$5.6M	Buy	+120,939	New	+$5.94M	0.54%	58
2025 Q1	–	Sell	-33,984	Closed	-$1.92M	–	441
2024 Q4	$1.92M	Buy	33,984 +20,852	+159%	+$1.17M	0.26%	137
2024 Q3	$679K	Sell	13,132 -12,253	-48%	-$575K	0.13%	229
2024 Q2	$1.05M	Buy	+25,385	New	+$1.14M	0.2%	163
2024 Q1	–	Sell	-70,017	Closed	-$3.59M	–	414
2023 Q4	$3.59M	Buy	70,017 +7,117	+11%	+$374K	0.9%	18
2023 Q3	$3.65M	Buy	+62,900	New	+$3.85M	0.68%	51
2023 Q1	–	Sell	-22,900	Closed	-$1.65M	–	248
2022 Q4	$1.65M	Buy	+22,900	New	+$1.73M	1.15%	10

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qsemble Capital Management's BMY Position: Q1 2026 in Review

Qsemble Capital Management increased its Bristol-Myers Squibb (BMY) stake by 169% in Q1 2026, buying an estimated $2.81M and bringing the position to 76,793 shares worth $4.66M. The position accounts for 0.36% of the portfolio, ranked #98.

Qsemble Capital Management first reported a position in BMY in Q4 2022 and has held it in 10 quarters since. The position peaked at $10.6M in Q3 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Qsemble Capital Management held 76,793 shares of Bristol-Myers Squibb worth $4.66M as of Q1 2026.
Qsemble Capital Management bought 48,266 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.81M.
Bristol-Myers Squibb made up 0.36% of Qsemble Capital Management's portfolio in Q1 2026, its #98 holding.
Qsemble Capital Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 10 quarters since.
Qsemble Capital Management's Bristol-Myers Squibb position peaked at $10.6M in Q3 2025.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.